BNTC

Benitec Biopharma Inc.

$13.44 +0.24 (+1.82%) At close · Jul 7

Market Cap

$461.72M

34,354,334

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-05-14	Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update	Event
2026-04-28	Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting	Shareholder meeting
2026-03-10	Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development for Oculopharyngeal Muscular Dystrophy (OPMD)	Conference
2026-03-09	Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference	Conference
2026-02-23	Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at the Muscular Dystrophy Association Clinical & Scientific Conference	Conference
2026-02-12	Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update	Event
2026-01-11	Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response	Event
2025-11-14	Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update	Event
2025-11-06	Benitec Biopharma Inc. Announces Pricing of $100 Million Common Stock Offering	Event
2025-11-05	Benitec Biopharma Inc. Announces Proposed Public Offering	Event

Source: https://ir.benitec.com/

Key facts CIK 1808898 CUSIP 08205P209 13F (30d) 1 filings 1 filers Visit website Investor relations